DexCom (DXCM) PT Raised to $650 at Piper Sandler After Endocrinologist Survey Shows T2 Adoption Acceleration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 84.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.41 | 52 Week High | $96.38 | |||
| Open | $84.41 | 52 Week Low | $47.92 | |||
| Day High | $84.41 | P/E | N/A | |||
| Day Low | $84.41 | EPS | $-0.42 | |||
| Volume | 159 | |||||
